Q2 2026 saw 14% revenue growth and 38% EPS growth year-over-year, with strong performance in both MedTech & Specialty Audio and Precision Devices segments. Full-year revenue is expected to grow 10%-12%, driven by robust demand, margin expansion, and a healthy backlog.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.